日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer

更正：miR-630靶向IGF1R，调节HER2过表达乳腺癌中对HER靶向药物的反应和癌细胞的整体进展。

期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-025-02251-8
Corcoran, Claire; Rani, Sweta; Breslin, Susan; Gogarty, Martina; Ghobrial, Irene M; Crown, John; O'Driscoll, Lorraine
肿瘤
HER2
肿瘤免疫
IGF1
乳腺癌
细胞生物学
发表日期：2025
文献求助 收藏

Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization

更正：开发并进行体外和离体表征一种双纳米颗粒系统，以增强眼部吸收并延长地塞米松在眼内的滞留时间：从实验室到中试规模的优化

期刊:Nanoscale Advances
影响因子:4.6
doi:10.1039/d5na90032h
Sarfraz, Muhammad; Behl, Gautam; Rani, Sweta; O'Reilly, Niall; McLoughlin, Peter; O'Donovan, Orla; Reynolds, Alison L; Lynch, John; Fitzhenry, Laurence
发表日期：2025
文献求助 收藏

Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization

开发并进行体外和离体表征一种双纳米颗粒系统，以增强地塞米松的眼部吸收并延长其在眼内的滞留时间：从实验室到中试规模的优化

期刊:Nanoscale Advances
影响因子:4.6
doi:10.1039/d4na01086h
Sarfraz, Muhammad; Behl, Goutam; Rani, Sweta; O'Reilly, Niall; McLoughlin, Peter; O'Donovan, Orla; Reynolds, Alison L; Lynch, John; Fitzhenry, Laurence
发表日期：2025
文献求助 收藏

Artificial Intelligence and the Evolving Landscape of Immunopeptidomics

人工智能与免疫肽组学的演变格局

期刊:Proteomics Clinical Applications
影响因子:2.5
doi:10.1002/prca.70018
Vo, Thanh Hoa; McNeela, Edel; O'Donovan, Orla; Rani, Sweta; Mehta, Jai Prakash
免疫/内分泌
发表日期：2025
文献求助 收藏

Editorial expression of concern: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer

编辑关注声明：miR-630靶向IGF1R，调节HER2过表达乳腺癌中对HER靶向药物的反应和癌细胞的整体进展

期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-024-02139-z
Corcoran, Claire; Rani, Sweta; Breslin, Susan; Gogarty, Martina; Ghobrial, Irene M; Crown, John; O'Driscoll, Lorraine
肿瘤
HER2
肿瘤免疫
IGF1
乳腺癌
细胞生物学
发表日期：2024
文献求助 收藏

Mechanism of miRNAs and miRNA-mRNA Regulatory Networks in Modulating Drug Resistance in HER2-Positive Breast Cancer: An Integrative Bioinformatics Approach

miRNA及其miRNA-mRNA调控网络在HER2阳性乳腺癌耐药性调控中的机制：一种整合生物信息学方法

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16233962
Vo, Thanh Hoa; McNeela, Edel A; O'Donovan, Orla; Rani, Sweta; Mehta, Jai Prakash
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
miRNA
发表日期：2024
文献求助 收藏

miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: A systematic review

miRNA作为乳腺癌HER2靶向治疗疗效的生物标志物：系统评价

期刊:Biochemistry and Biophysics Reports
影响因子:2.2
doi:10.1016/j.bbrep.2023.101588
Vo, Thanh Hoa; El-Sherbieny Abdelaal, Esam; Jordan, Emmet; O'Donovan, Orla; McNeela, Edel A; Mehta, Jai Prakash; Rani, Sweta
肿瘤
HER2
肿瘤免疫
乳腺癌
miRNA
发表日期：2024
文献求助 收藏

Investigation of novel combination therapy for age-related macular degeneration on ARPE-19 cells

利用ARPE-19细胞研究治疗年龄相关性黄斑变性的新型联合疗法

期刊:Frontiers in Drug Delivery
影响因子:
doi:10.3389/fddev.2024.1337686
Dandamudi, Madhuri; McLoughlin, Peter; Behl, Gautam; Coffey, Lee; Chauhan, Anuj; Kent, David; Rani, Sweta; Fitzhenry, Laurence
细胞生物学
发表日期：2024
文献求助 收藏

Two decades of two-photon lithography: Materials science perspective for additive manufacturing of 2D/3D nano-microstructures.

双光子光刻技术二十年：二维/三维纳米微结构增材制造的材料科学视角

期刊:iScience
影响因子:4.1
doi:10.1016/j.isci.2023.106374
Jaiswal Arun, Rastogi Chandresh Kumar, Rani Sweta, Singh Gaurav Pratap, Saxena Sumit, Shukla Shobha
发表日期：2023
文献求助 收藏

Immune System, Inflammation and Autoantigens in Wet Age-Related Macular Degeneration: Pathological Significance and Therapeutic Importance

湿性年龄相关性黄斑变性中的免疫系统、炎症和自身抗原：病理意义和治疗价值

期刊:Life-Basel
影响因子:3.4
doi:10.3390/life13122236
Manikandan, Sreeraj Kuruppilakath; Logan, Ann; Cerrada-Gimenez, Marc; Fitzhenry, Laurence; Coffey, Lee; Kaja, Simon; Rani, Sweta
炎症/感染
Immunology/Inflammation
炎症
免疫/内分泌
发表日期：2023
文献求助 收藏